What Is NAD Plus: Biomarker Context and Metabolic Precision

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells, essential for energy metabolism and DNA repair. NAD+ levels naturally decline with age, dropping approximately 50% by age 60, which may impact cellular function and metabolic efficiency.

For precision-wellness patients, NAD+ represents a measurable biomarker reflecting mitochondrial health and metabolic capacity. Understanding your NAD+ status can support more informed conversations with your healthcare provider about metabolic optimization and personalized treatment approaches.

Core Functions of NAD+ in Cellular Energy

NAD+ acts as a critical electron shuttle in glycolysis, the citric acid cycle, and the electron transport chain—the three major pathways that convert glucose into ATP (cellular energy). Without sufficient NAD+, cells cannot efficiently generate the energy required for all metabolic processes, from muscle contraction to protein synthesis.

NAD+ also activates sirtuins, a family of enzymes involved in stress resistance, DNA repair, and mitochondrial biogenesis. When NAD+ levels are low, sirtuin activity diminishes, potentially accelerating age-related cellular decline and metabolic dysfunction.

NAD+ Metabolism: From Dietary Sources to Biomarker Status

NAD+ is synthesized from the amino acid tryptophan and the vitamin B3 (niacin) pathway. Dietary sources include chicken, tuna, turkey, mushrooms, and green peas. Your body also recycles NAD+ via salvage pathways, meaning biomarker NAD+ status reflects both intake and cellular recycling efficiency.

NAD+ Metabolic Factor	Clinical Relevance
NAD+ biosynthesis pathway	De novo synthesis from tryptophan; impacted by B3 intake and enzyme function
NAD+ salvage pathway	Recycling of NAD+ precursors (nicotinamide); becomes less efficient with age
Mitochondrial NAD+ pool	Separate from cytoplasmic NAD+; critical for energy production in oxidative metabolism
NAD+/NADH ratio	Indicates cellular redox state; low ratios suggest impaired energy metabolism and oxidative stress

Age-Related NAD+ Decline and Metabolic Health

NAD+ levels decline progressively across the lifespan due to increased consumption by DNA-repair enzymes (PARPs) and age-related mitochondrial dysfunction. By midlife, this decline correlates with reduced insulin sensitivity, decreased muscle mass, and impaired metabolic flexibility—the ability to switch between carbohydrate and fat oxidation.

Research in model organisms and human cohorts suggests that NAD+ status may influence body composition, glucose metabolism, and metabolic rate. However, biomarker NAD+ levels are not a standalone predictor of metabolic outcomes; they reflect one aspect of mitochondrial health that should be interpreted alongside other markers and clinical assessment.

Assessing NAD+ Status and Personalized Metabolic Conversations

NAD+ can be measured in blood serum or peripheral blood mononuclear cells; however, these measurements do not fully capture tissue-specific NAD+ pools or sirtuin activity. A single NAD+ measurement provides a snapshot, not a complete picture of metabolic function. Your provider should contextualize NAD+ results alongside fasting glucose, insulin levels, lipid panels, and resting metabolic rate.

When evaluating NAD+ as part of precision-wellness planning, consider whether interventions targeting NAD+ metabolism—such as niacin supplementation, exercise, or caloric restriction—align with your broader metabolic goals. PlexusDx's Precision Peptide Genetic Test can reveal genetic predispositions in metabolic pathways, which may help contextualize how your body handles energy substrate and inform discussions with your provider about personalized metabolic optimization strategies.

How PlexusDx Supports a More Personalized Approach

NAD+ status is a biomarker window into mitochondrial health and metabolic capacity. PlexusDx emphasizes that biomarker context—including NAD+ levels, glucose metabolism markers, and genetic predispositions—can collectively support a more nuanced conversation between you and your healthcare provider about personalized metabolic interventions.

The Precision Peptide Genetic Test reveals predispositions in metabolic and energy-regulation pathways, including variants affecting mitochondrial function and glucose handling. These genetic insights may help provide context for why your body responds to certain metabolic stressors or dietary approaches differently, but genetic predisposition does not predict exact biomarker values or treatment response.

Understanding NAD+ alongside your genetic metabolic profile and current biomarker status can support a more informed, personalized conversation with your provider about whether NAD+-targeted interventions, metabolic optimization protocols, or other precision-wellness strategies align with your health goals and baseline metabolic capacity.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the normal range for NAD+ levels in blood?

Normal serum NAD+ ranges approximately 500–700 μM, though reference ranges vary by lab and measurement method. Your provider should interpret your result alongside clinical symptoms, age, and metabolic markers rather than in isolation.

How can I naturally increase NAD+ levels?

Evidence-supported approaches include caloric restriction or intermittent fasting, regular aerobic and resistance exercise, adequate B3 (niacin) intake, and quality sleep. These interventions support NAD+ salvage and mitochondrial biogenesis, though individual response varies.

Does the Precision Peptide Genetic Test measure NAD+ levels?

No. The Precision Peptide Genetic Test reveals predispositions in metabolic and energy pathways (FTO, MC4R variants) but does not directly measure NAD+. It provides genetic context that may support discussions about metabolic optimization with your provider.

Are NAD+ supplements effective for weight loss or metabolic health?

NAD+ precursor supplements (NMN, NR) show promise in animal and some human studies, but clinical evidence in human weight loss is limited. Any supplement should be evaluated with your provider, especially if you take medications affecting metabolism.

How does NAD+ relate to GLP-1 or metabolic peptide therapy?

GLP-1 and metabolic peptides work through distinct signaling pathways but both influence mitochondrial function and cellular energy efficiency. Biomarker NAD+ status may reflect your baseline metabolic capacity, which can support personalized conversations about whether metabolic optimization or peptide therapy is appropriate for your goals.